Stefania Crucitta
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 20
-
- Lung Cancer Treatments and Mutations 18
- Prostate Cancer Treatment and Research 9
- Advanced Breast Cancer Therapies 8
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 9
- Colorectal Cancer Treatments and Studies 6
- Cancer Immunotherapy and Biomarkers 6
- Molecular Biology top 10%
- PI3K/AKT/mTOR signaling in cancer 6
- Genetics top 10%
- Co-authors
- Marzia Del ReRomano DanesiEleonora RofiIacopo PetriniGiuliana RestanteStefano FogliAlfredo FalconeE. Arrigoni
- Partner nations
- ItalyNetherlandsUnited States
In The Last Decade
Stefania Crucitta
61 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 90
- Cancer Research 618
- Pulmonary and Respiratory Medicine 770
- Oncology 612
- Molecular Biology 727
- Genetics 93
Countries citing papers authored by Stefania Crucitta
This map shows the geographic impact of Stefania Crucitta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefania Crucitta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefania Crucitta more than expected).
Fields of papers citing papers by Stefania Crucitta
This network shows the impact of papers produced by Stefania Crucitta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefania Crucitta. The network helps show where Stefania Crucitta may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stefania Crucitta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 17 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 11 | |
| 5 | 2022 | 4 | |
| 6 | 2022 | 3 | |
| 7 | 2021 | 24 | |
| 8 | 2021 | 12 | |
| 9 | 2021 | 43 | |
| 10 | 2021 | 2 | |
| 11 | 2020 | 52 | |
| 12 | 2020 | 29 | |
| 13 | 2020 | 28 | |
| 14 | 2019 | 62 | |
| 15 | 2019 | 13 | |
| 16 | 2018 | 38 | |
| 17 | 2018 | 7 | |
| 18 | 2017 | 1 | |
| 19 | 2016 | 1 | |
| 20 | 2016 | 224 |
About Stefania Crucitta
Stefania Crucitta is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 65 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (20 papers), Lung Cancer Treatments and Mutations (18 papers), Pancreatic and Hepatic Oncology Research (9 papers), Prostate Cancer Treatment and Research (9 papers), Advanced Breast Cancer Therapies (8 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). The work is most often cited by research in Cancer Research (618 citations), Pulmonary and Respiratory Medicine (770 citations) and Oncology (612 citations). Stefania Crucitta has collaborated with scholars based in Italy, Netherlands and United States. Frequent co-authors include Marzia Del Re, Romano Danesi, Eleonora Rofi, Iacopo Petrini, Giuliana Restante, Stefano Fogli, Alfredo Falcone, E. Arrigoni, Federico Cucchiara and Lisa Derosa. Their work appears in journals such as Annals of Oncology, Cancer Treatment Reviews, Cancers, Critical Reviews in Oncology/Hematology and Pharmacogenomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.